Loading chat...

MA H2372

Bill

Official Source

Status

Introduced

2/27/2025

Primary Sponsor

Christine Barber

Click for details

Origin

House of Representatives

194th General Court

AI Summary

  • Expands collaborative drug therapy management to ambulatory care clinics licensed under section 51 of chapter 111 of the General Laws
  • Requires on-site or off-site supervision by both an attending physician and a collaborating pharmacist
  • Requires approval from the ambulatory care clinic's medical staff executive committee, designee, medical director, or designee
  • Creates an exception to existing restrictions in section 24 B1/2 of chapter 112 of the General Laws governing pharmacist practice
  • Similar legislation was filed in the previous session as House No. 2134 of 2023-2024

Legislative Description

Relative to collaborative drug therapy management optimization

Last Action

Reporting date extended to Wednesday, March 18, 2026

12/8/2025

Committee Referrals

Health Care Financing7/24/2025
Public Health2/27/2025

Full Bill Text

No bill text available